155 related articles for article (PubMed ID: 17073645)
1. Modulation of hepatocyte apoptosis: cross-talk between bile acids and nuclear steroid receptors.
Solá S; Amaral JD; Aranha MM; Steer CJ; Rodrigues CM
Curr Med Chem; 2006; 13(25):3039-51. PubMed ID: 17073645
[TBL] [Abstract][Full Text] [Related]
2. Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes.
Solá S; Castro RE; Kren BT; Steer CJ; Rodrigues CM
Biochemistry; 2004 Jul; 43(26):8429-38. PubMed ID: 15222754
[TBL] [Abstract][Full Text] [Related]
3. Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF-beta1-induced apoptosis in rat hepatocytes.
Solá S; Amaral JD; Castro RE; Ramalho RM; Borralho PM; Kren BT; Tanaka H; Steer CJ; Rodrigues CM
Hepatology; 2005 Oct; 42(4):925-34. PubMed ID: 16175607
[TBL] [Abstract][Full Text] [Related]
4. p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis.
Amaral JD; Castro RE; Solá S; Steer CJ; Rodrigues CM
J Biol Chem; 2007 Nov; 282(47):34250-9. PubMed ID: 17881359
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor beta1-induced apoptosis of rat hepatocytes.
Sola S; Ma X; Castro RE; Kren BT; Steer CJ; Rodrigues CM
J Biol Chem; 2003 Dec; 278(49):48831-8. PubMed ID: 14514686
[TBL] [Abstract][Full Text] [Related]
6. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
[TBL] [Abstract][Full Text] [Related]
7. Bile Acids as Signaling Molecules: Role of Ursodeoxycholic Acid in Cholestatic Liver Disease.
Cifuentes-Silva E; Cabello-Verrugio C
Curr Protein Pept Sci; 2024; 25(3):206-214. PubMed ID: 37594109
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulating and anti-apoptotic action of ursodeoxycholic acid: where are we and where should we go?
Bellentani S
Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):137-40. PubMed ID: 15674088
[TBL] [Abstract][Full Text] [Related]
9. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation.
Rodrigues CM; Fan G; Ma X; Kren BT; Steer CJ
J Clin Invest; 1998 Jun; 101(12):2790-9. PubMed ID: 9637713
[TBL] [Abstract][Full Text] [Related]
10. Bile acids: regulation of apoptosis by ursodeoxycholic acid.
Amaral JD; Viana RJ; Ramalho RM; Steer CJ; Rodrigues CM
J Lipid Res; 2009 Sep; 50(9):1721-34. PubMed ID: 19417220
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.
Munoz-Garrido P; Marin JJ; Perugorria MJ; Urribarri AD; Erice O; Sáez E; Úriz M; Sarvide S; Portu A; Concepcion AR; Romero MR; Monte MJ; Santos-Laso Á; Hijona E; Jimenez-Agüero R; Marzioni M; Beuers U; Masyuk TV; LaRusso NF; Prieto J; Bujanda L; Drenth JP; Banales JM
J Hepatol; 2015 Oct; 63(4):952-61. PubMed ID: 26044126
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic effects of ursodeoxycholic acid as an anti-apoptotic agent.
Rodrigues CM; Steer CJ
Expert Opin Investig Drugs; 2001 Jul; 10(7):1243-53. PubMed ID: 11772248
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma.
Lim SC; Choi JE; Kang HS; Han SI
Int J Cancer; 2010 Apr; 126(7):1582-95. PubMed ID: 19728331
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
Pusl T; Beuers U
World J Gastroenterol; 2006 Jun; 12(22):3487-95. PubMed ID: 16773706
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications.
Roma MG; Toledo FD; Boaglio AC; Basiglio CL; Crocenzi FA; Sánchez Pozzi EJ
Clin Sci (Lond); 2011 Dec; 121(12):523-44. PubMed ID: 21854363
[TBL] [Abstract][Full Text] [Related]
16. Role of nuclear steroid receptors in apoptosis.
Amaral JD; Solá S; Steer CJ; Rodrigues CM
Curr Med Chem; 2009; 16(29):3886-902. PubMed ID: 19747134
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.
Paumgartner G; Beuers U
Hepatology; 2002 Sep; 36(3):525-31. PubMed ID: 12198643
[TBL] [Abstract][Full Text] [Related]
18. Effects of ursodeoxycholic acid, analogues of ursodeoxycholic acid and combination of bile acids on bile acid synthesis in cultured rat hepatocytes.
Kubaska WM; Gurley EC; Hylemon PB; Heuman DM; Mosbach EH; Vlahcevic ZR
Biochim Biophys Acta; 1987 Aug; 920(3):195-204. PubMed ID: 3607077
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular bile acid transport and ursodeoxycholic acid hypercholeresis.
Scharschmidt BF; Lake JR
Dig Dis Sci; 1989 Dec; 34(12 Suppl):5S-15S. PubMed ID: 2689116
[TBL] [Abstract][Full Text] [Related]
20. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
